SCHEMBL189322

SCHEMBL189322

Oc1ccc(F)c(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29427145 1.00 — —
SCHEMBL31348999 0.81 ESR2 (0.50) —
SCHEMBL177370 0.79 — —
SCHEMBL29692338 0.79 — —
SCHEMBL3395849 0.77 NPC1 (0.65) —
SCHEMBL2277159 0.75 MAPT (0.56) —
SCHEMBL13263896 0.75 CES2 (0.53) —
SCHEMBL15552163 0.75 ESR1 (0.48) —
SCHEMBL31521715 0.75 ESR1 (0.41) —
SCHEMBL15677 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 793 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478199-A Bimetallic catalyst and preparation method thereof, and preparation method of high molecular weight olefin polymer 万华化学集团股份有限公司 2023-07-25 — — CN claimed
CN-100564339-C 2, the preparation method of 3-two fluoro-5-bromophenols SHANGHAI KANGPENG CHEMICAL CO (CN) 2009-12-02 — — CN claimed
CN-101037380-A Preparation method of 2,3-Difluoro-5-Bromophenol SHANGHAI KANGPENG CHEMICAL CO (CN) 2007-09-19 — — CN claimed
CN-1301946-C Preparation method of 2.3-difluoro-5-bromophenol FUXIN JINHONGTAI CHEMICAL CO L (CN) 2007-02-28 — — CN claimed
CN-1789224-A Preparation method of 2.3-difluoro-5-bromophenol FUXIN JINHONGTAI CHEMICAL CO L (CN) 2006-06-21 — — CN claimed
EP-4747247-A1 NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF Apogee Pharmaceuticals, Inc. (CA) 2026-05-27 — — EP disclosed
US-12630528-B2 Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof LG CHEM, LTD. (KR) 2026-05-19 — — US disclosed
US-12624051-B2 Macrocyclic compounds, compositions, and methods of using thereof GENZYME CORPORATION (US) 2026-05-12 — — US disclosed
US-12577242-B2 Pyrrolopyridine and imidazopyridine antiviral compounds KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2026-03-17 — — US disclosed
US-12552770-B2 Compounds for treating respiratory disease TMEM16A LIMITED (GB) 2026-02-17 — — US disclosed
US-20260034127-A1 TREATMENT OF GVHD KADMON CORP LLC (FR) 2026-02-05 — — US disclosed
US-20260035361-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) SHANGHAI DEGRON BIOMEDICAL TECH CO LTD (CN) 2026-02-05 — — US disclosed
WO-2000026182-A1 2-PHENOXYPHENYLACETIC ACID DERIVATIVES, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, THEIR USE, AND AGENTS CONTAINING THE SAME FOR COMBATING FUNGICIDAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2000-05-11 — — WO disclosed
US-5112523-A High clearing point for liquid crystal displays CHISSO CORPORATION (JP) 1992-05-12 — — US disclosed
CN-1015545-B preparation method of glycolic acid derivative for treating diabetic complications PFIZER (US) 1992-02-19 — — CN disclosed
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 — — EP disclosed
US-4874546-A LIQUID CRYSTALS CHISSO CORPORATION (JP) 1989-10-17 — — US disclosed
CN-87100191-A The hydroxy acid derivative of treatment diabetic complication — 1987-09-09 — — CN disclosed
WO-1987004344-A1 HYDROXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1987-07-30 — — WO disclosed
EP-0230379-A2 Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications PFIZER INC. (US) 1987-07-29 — — EP disclosed
Send feedback